Salih Suha Koparal
Salih Suha Koparal has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
- Bülent Özkurt
University of Health Sciences
1 shared publication - Derya Koseoglu
Samsun Üniversitesi
1 shared publication - Dilek Berker
Department of Endocrinology and Metabolism, University of Health Sciences, Retired Lecturer, Ankara, Turkiye
1 shared publication - Filiz Eser
Department of Physical Medicine and Rehabilitation, Ankara Numune Training and Research Hospital, Ankara, Turkey
1 shared publication - Tarik Ozmen
Department of Physiotherapy and Rehabilitation, Faculty of Health Sciences, Karabük University, Karabük, Turkey
1 shared publication - Tuba Ümit Gafuroğlu
University of Health Sciences
1 shared publication
Latest Publications
- Open Access
- 26 February 2021
- Published by The Scientific and Technological Research Council of Turkey (TUBITAK-ULAKBIM) - DIGITAL COMMONS JOURNALS in TURKISH JOURNAL OF MEDICAL SCIENCES
- Vol. 51 (1) , 167-174
Exenatide improves cardiovascular risk factors in obese patients with type 2 diabetes mellitus: a prospective study
The aim of this study was to evaluate the effects of 6-months treatment with exenatide on lipid profile, high sensitivity C-reactive protein (hsCRP), carotid intima media thickness (CIMT), visceral adiposity and non-alcoholic fatty liver disease (NAFLD), which are all important cardiovascular risk factors. This study included 45 obese patients with type 2 diabetes mellitus (T2DM). The baseline clinical findings, laboratory parameters and ultrasonography findings were recorded. Exenatide twice daily recipe was given to these patients and after 6 months of therapy the same variables were compared. The compared parameters were lipid profiles, hsCRP, aspartat aminotransferase, alanine aminotransferase, gamma-glutamyltransferase, liver craniocaudal diameter, visceral fat volume, subcutaneous fat thickness and CIMT. Liver diameter, visceral fat volume and subcutaneous fat thickness and CIMT were measured with ultrasonography. After therapy, statistically significant improvement were achieved in lipid profile, hsCRP, liver enzymes, body mass index, waist and hip circumferences. Also statistically significant decrease were obtained in liver craniocaudal diameter, subcutaneous fat thickness, visceral fat volume and CIMT. The reduction of CIMT and liver diameter were not correlated with BMI and HbA1c reduction. This study showed improvement in lipid profile and hsCRP levels with exenatide treatment. We also showed decrease in both visceral fat volume and subcutaneous fat thickness. We demonstrated significant decrease in liver enzymes with significant decrease in liver diameter. These findings supports the use of exenatide in patients with NAFLD and T2DM. Additionally this study showed that twice daily exenatide treatment reduces CIMT in obese T2DM patients.
- 26 February 2021
- Published by The Scientific and Technological Research Council of Turkey (TUBITAK-ULAKBIM) - DIGITAL COMMONS JOURNALS in TURKISH JOURNAL OF MEDICAL SCIENCES
- Vol. 51 (1) , 167-174
Open AccessExenatide improves cardiovascular risk factors in obese patients with type 2 diabetes mellitus: a prospective study
The aim of this study was to evaluate the effects of 6-months treatment with exenatide on lipid profile, high sensitivity C-reactive protein (hsCRP), carotid intima media thickness (CIMT), visceral adiposity and non-alcoholic fatty liver disease (NAFLD), which are all important cardiovascular risk factors. This study included 45 obese patients with type 2 diabetes mellitus (T2DM). The baseline clinical findings, laboratory parameters and ultrasonography findings were recorded. Exenatide twice daily recipe was given to these patients and after 6 months of therapy the same variables were compared. The compared parameters were lipid profiles, hsCRP, aspartat aminotransferase, alanine aminotransferase, gamma-glutamyltransferase, liver craniocaudal diameter, visceral fat volume, subcutaneous fat thickness and CIMT. Liver diameter, visceral fat volume and subcutaneous fat thickness and CIMT were measured with ultrasonography. After therapy, statistically significant improvement were achieved in lipid profile, hsCRP, liver enzymes, body mass index, waist and hip circumferences. Also statistically significant decrease were obtained in liver craniocaudal diameter, subcutaneous fat thickness, visceral fat volume and CIMT. The reduction of CIMT and liver diameter were not correlated with BMI and HbA1c reduction. This study showed improvement in lipid profile and hsCRP levels with exenatide treatment. We also showed decrease in both visceral fat volume and subcutaneous fat thickness. We demonstrated significant decrease in liver enzymes with significant decrease in liver diameter. These findings supports the use of exenatide in patients with NAFLD and T2DM. Additionally this study showed that twice daily exenatide treatment reduces CIMT in obese T2DM patients.
- Open Access
- 26 February 2021
- Published by The Scientific and Technological Research Council of Turkey (TUBITAK-ULAKBIM) - DIGITAL COMMONS JOURNALS in TURKISH JOURNAL OF MEDICAL SCIENCES
- Vol. 51 (1) , 76-83
Comparison of the clinical and sonographic effects of ultrasound therapy, extracorporeal shock wave therapy, and Kinesio taping in lateral epicondylitis
The aim of this study was to compare the clinical and sonographic effects of the ultrasound (US) therapy, extracorporeal shock wave therapy (ESWT), and Kinesio taping (KT) in the lateral epicondylitis (LE). A total of 40 patients with LE were included in the present study. The patients were randomly assigned to three treatment groups: US (n = 13), ESWT (n = 14), and KT (n = 13) groups. The visual analog scale (VAS) scores significantly decreased in all groups (p < 0.05). Grip strength significantly increased after eight weeks in only the KT group (p < 0.05). The Patient-Rated Tennis Elbow Evaluation Scale (PRTEE) scores significantly decreased after two weeks and after eight weeks in the US and ESWT groups and after eight weeks in the KT group (p < 0.05). The common extensor tendon (CET) thicknesses significantly decreased after eight weeks in only the ESWT group (p < 0.05). The US therapy, KT, and ESWT are effective in reducing pain and improving functionality. However, none of these treatment methods were found to be superior to the others in reducing the pain and improving functionality.
- 26 February 2021
- Published by The Scientific and Technological Research Council of Turkey (TUBITAK-ULAKBIM) - DIGITAL COMMONS JOURNALS in TURKISH JOURNAL OF MEDICAL SCIENCES
- Vol. 51 (1) , 76-83
Open AccessComparison of the clinical and sonographic effects of ultrasound therapy, extracorporeal shock wave therapy, and Kinesio taping in lateral epicondylitis
The aim of this study was to compare the clinical and sonographic effects of the ultrasound (US) therapy, extracorporeal shock wave therapy (ESWT), and Kinesio taping (KT) in the lateral epicondylitis (LE). A total of 40 patients with LE were included in the present study. The patients were randomly assigned to three treatment groups: US (n = 13), ESWT (n = 14), and KT (n = 13) groups. The visual analog scale (VAS) scores significantly decreased in all groups (p < 0.05). Grip strength significantly increased after eight weeks in only the KT group (p < 0.05). The Patient-Rated Tennis Elbow Evaluation Scale (PRTEE) scores significantly decreased after two weeks and after eight weeks in the US and ESWT groups and after eight weeks in the KT group (p < 0.05). The common extensor tendon (CET) thicknesses significantly decreased after eight weeks in only the ESWT group (p < 0.05). The US therapy, KT, and ESWT are effective in reducing pain and improving functionality. However, none of these treatment methods were found to be superior to the others in reducing the pain and improving functionality.